The AI Eye: Amazon (Nasdaq: $AMZN) Teams with 30 Leading Tech Firms to Announce Voice Interoperability Initiative and Watson Health (NYSE: $IBM) Signs Agreement with Guerbet for AI Prostate Cancer Solution
Point Roberts, WA and Vancouver, BC - September 24, 2019 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today's edition of The AI Eye - watching stock news, deal tracker and advancements in artificial intelligence.
Listen to today's podcast:
The #AI Eye: Amazon (Nasdaq: $AMZN) Teams with 30 Leading Tech Firms to Announce Voice Interoperability Initiative and Watson Health (NYSE: $IBM) Signs Agreement with Guerbet for AI Prostate Cancer Solution
Today's Column - The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence
Stocks discussed: (NasdaqGS:AMZN) (NYSE:IBM) (OTC:GUERF)
Amazon (NasdaqGS:AMZN), along with several other leading tech companies, has announced the Voice Interoperability Initiative, a new program designed to ensure that voice services will work seamlessly alongside one another on a single device, and that voice-enabled products should be designed to support multiple simultaneous wake words. More than 30 companies are supporting the project, which lists as its chief aims:
- Developing voice services that can work seamlessly with others, while protecting the privacy and security of customers
- Building voice-enabled devices that promote choice and flexibility through multiple, simultaneous wake words
- Releasing technologies and solutions that make it easier to integrate multiple voice services on a single product
- Accelerating machine learning and conversational AI research to improve the breadth, quality and interoperability of voice services
Amazon founder and CEO Jeff Bezos commented:
"Multiple simultaneous wake words provide the best option for customers. Utterance by utterance, customers can choose which voice service will best support a particular interaction. It's exciting to see these companies come together in pursuit of that vision."
Watson Health, a unit of IBM (NYSE:IBM), has signed an agreement with medical imaging contrast agents manufacturer Guerbet (OTC:GUERF) to co-develop and co-commercialize an artificial intelligence (AI) solution to help clinicians diagnose and monitor patients with prostate cancer. David Gruen, M.D., Chief Medical Officer, Imaging, IBM Watson Health, explained:
"The main diagnostic challenge with prostate cancer lies in identifying cancers requiring rapid treatment and those requiring only active surveillance, while avoiding unnecessary biopsies. For this reason, optimal patient outcomes depend on the rapid and accurate diagnosis and treatments that AI technologies can potentially help provide."
Global AI-Enabled Medical Imaging Market to See 30.95% CAGR from 2019-2029
A report from Research and Markets finds that the global AI-enabled Medical Imaging market, which generated revenue of $404 million USD in 2018, will see a compound annual growth rate (CAGR) of 30.95 percent in the forecast period 2019 to 2029. An excerpt from the report description reads:
The market growth in the global AI-enabled medical imaging solutions market can primarily be attributed to the factors such as expanding the range of applications of AI, shortage of healthcare workforce, and huge R&D investments as well as fundings. However, there are significant challenges which are restraining the market growth. These challenges include privacy and security concerns related to healthcare data and barriers to physician's adoption of AI.
Sam Mowers, Investorideas.com
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.
Visit the Podcast page at Investorideas.com:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
800 665 0411